SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?


To: Trader J who wrote (22583)11/5/1999 1:30:00 PM
From: BarbaraT  Respond to of 56532
 
<ggg>



To: Trader J who wrote (22583)11/5/1999 1:43:00 PM
From: Canuck Dave  Respond to of 56532
 
I can see I'm going to have to start paying attention again.

This is starting to feel like school, except for all the money.

CD



To: Trader J who wrote (22583)11/5/1999 4:14:00 PM
From: Norm Demers  Respond to of 56532
 
PSS WORLD MEDICAL, INC. (PSSI: $8.50)* 11/04/99
Initiating Coverage With A Buy Rating
Earnings Per Share Old New P/E Ratios
(FY:Mar.) 2001E $1.05 $ 8.1
2000E 0.88 9.7
1999A 0.76 11.2

Rating: BUY Change: None 12-Mo. Target: $16

We are initiating coverage of PSS World Medical, Inc. (PSSI) with a Buy rating. Through strong internal growth and numerous acquisitions, PSSI has grown to become the largest distributor of medical supplies to physician offices in the United States with sales of $677 million in fiscal (March) 1999. In 1999, PSSI recorded record revenues of $1.6 billion, up 177% from the $564 million reported in 1995. The stock hit an all-time high of $34 three-and-one-half years ago. In 1999, PSSI has fallen 63% from its December 31, 1998 level of $23.00. The equities of other distribution companies also have been severely punished this year, e.g., the four major drug wholesalers also are down 63% this year. Although PSSI has bounced off its 12-month low of $6.00, hit in mid-October, at $8.50 it remains only modestly above its book value of $6.06 per share. The multiple on fiscal 2000 earnings is only 9.7 times, a 65% discount to the market. On our calendar year 2000 estimate of $1.01, the multiple is just 8.4 times. Although the industry environment in which Gulf South operates does create a fair degree of uncertainty for PSSI's nearer-term earnings, we have a high regard for the company's management team and believe that this stock is attractively priced for aggressive, small cap portfolios. (PSSI's market capitalization is $605 million.) We rate the stock Buy with a one-year price target in a flat market at $15-17.



To: Trader J who wrote (22583)11/5/1999 6:53:00 PM
From: Canuck Dave  Read Replies (1) | Respond to of 56532
 
Jeff, you still got DIS on your long term lists? I just removed it from mine.

Lots of negative comments today, and tough times ahead. Competition, changing tastes, lack of imagination, you name it.

Incidentally, I've been doing pretty well with those drugs I'm taking. Thinking about selling them and going public. How about toomanystocks.com?

CD